clinical trial · NCT01626872
Long-Term Study of MP-214 in Patients With Schizophrenia
SchizophreniaMP-214 3mgMP-214 6mgMP-214 9mgRisperidone 4mg
brief summary
The objective of this study is to evaluate the long-term safety, tolerability, and efficacy of MP-214 in patients with schizophrenia.
started
Sep 1, 2012
primary completion
Oct 1, 2016
completion
Oct 1, 2016
last updated
Jan 5, 2026
official title
Long-Term Extension Study of MP-214 in Patients With Schizophrenia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol